Back to GetFilings.com



 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 


 

FORM 10-Q

 

(Mark one)

 

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2003

 

OR

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from            to           

 

 

Commission file number 000-32929

 


 

Monolithic System Technology, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

77-0291941

(State or other jurisdiction
of Incorporation or organization)

 

(I.R.S. Employer
Identification Number)

 

1020 Stewart Drive
Sunnyvale, California, 94085

(Address of principal executive office and zip code)

 

(408) 731-1800

(Registrant’s telephone number, including area code)

 


 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days.

YES ý  NO o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

YES ý  NO o

 

As of October 31, 2003, 30,693,756_shares of the Registrant’s common stock, $0.01 par value, were outstanding.

 

 



 

MONOLITHIC SYSTEM TECHNOLOGY, INC.

 

FORM 10-Q
September 30, 2003

 

INDEX

 

PART I—FINANCIAL INFORMATION

 

Item 1.

Financial Statements:

 

 

a.

Condensed Consolidated Balance Sheets as of September 30, 2003 (Unaudited) and December 31, 2002

 

 

 

 

b.

Condensed Consolidated Statements of Operations for the three months and nine months ended September 30, 2003 and 2002 (Unaudited)

 

 

 

 

c.

Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2003 and 2002 (Unaudited)

 

 

 

 

d.

Notes to Condensed Consolidated Financial Statements (Unaudited)

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

Item 3.

Qualitative and Quantitative Disclosure About Market Risk

 

 

Item 4.

Control and Procedures

 

PART II—OTHER INFORMATION

 

Item 2.

Changes In Securities and Use of Proceeds

 

 

Item 6.

Exhibits and Reports on Form 8-K

 

 

 

Signatures

 

2



 

PART I—FINANCIAL INFORMATION

 

Item 1. Financial Statements

MONOLITHIC SYSTEM TECHNOLOGY, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

 

 

 

September 30,
2003

 

December 31,
2002

 

 

 

(Unaudited)

 

 

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

28,865

 

$

26,321

 

Short-term investments

 

7,182

 

42,112

 

Accounts receivable, net

 

937

 

943

 

Unbilled contract receivables

 

1,204

 

693

 

Inventories

 

592

 

1,037

 

Prepaid expenses and other current assets

 

5,002

 

4,475

 

Total current assets

 

43,782

 

75,581

 

Long-term investments

 

48,302

 

11,400

 

Property and equipment, net

 

2,279

 

3,352

 

Goodwill

 

12,326

 

12,326

 

Other assets

 

509

 

431

 

Total assets

 

$

107,198

 

$

103,090

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

111

 

$

132

 

Accrued expenses and other liabilities

 

2,880

 

2,368

 

Deferred revenue

 

326

 

1,779

 

Current portion of capital lease obligations

 

14

 

89

 

Total current liabilities

 

3,331

 

4,368

 

Long-term portion of capital lease obligations

 

16

 

25

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $0.01 par value; 20,000 shares authorized; none issued and outstanding at September 30, 2003 and December 31, 2002

 

 

 

Common stock, $0.01 par value; 120,000 shares authorized; 30,638 shares and 30,230 shares issued and outstanding at September 30, 2003 and December 31, 2002

 

306

 

302

 

Additional paid-in capital

 

99,625

 

97,796

 

Deferred stock-based compensation

 

(664

)

(1,064

)

Accumulated other comprehensive income

 

114

 

116

 

Retained earnings

 

4,470

 

1,547

 

Total stockholders’ equity

 

103,851

 

98,697

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

107,198

 

$

103,090

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3



 

MONOLITHIC SYSTEM TECHNOLOGY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except per share amounts)

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

 

2003

 

2002

 

2003

 

2002

 

Net revenue:

 

 

 

 

 

 

 

 

 

Product

 

$

511

 

$

784

 

$

1,570

 

$

2,325

 

Licensing

 

1,780

 

2,756

 

8,489

 

7,260

 

Royalty

 

1,208

 

3,471

 

5,823

 

10,351

 

 

 

3,499

 

7,011

 

15,882

 

19,936

 

Cost of net revenue:

 

 

 

 

 

 

 

 

 

Product

 

260

 

465

 

958

 

1,295

 

Licensing

 

588

 

448

 

1,544

 

1,099

 

 

 

848

 

913

 

2,502

 

2,394

 

Gross profit

 

2,651

 

6,098

 

13,380

 

17,542

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

2,093

 

1,666

 

6,506

 

4,487

 

Selling, general and administrative

 

1,396

 

1,258

 

4,658

 

3,437

 

Stock based compensation

 

190

 

121

 

421

 

485

 

Total operating expenses

 

3,679

 

3,045

 

11,585

 

8,409

 

Income (loss) from operations

 

(1,028

)

3,053

 

1,795

 

9,133

 

Interest and other income

 

311

 

392

 

1,453

 

1,192

 

Income (loss) before income taxes

 

(717)

 

3,445

 

3,248

 

10,325

 

Benefit (provision) for income taxes

 

468

 

(689

)

(325

)

(2,064

)

Net income (loss)

 

$

(249)

 

$

2,756

 

$

2,923

 

$

8,261

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.01

$

0.09

 

$

0.10

 

$

0.28

 

Diluted

 

$

(0.01

$

0.09

 

$

0.09

 

$

0.26

 

Shares used in computing net income (loss) per share:

 

 

 

 

 

 

 

 

 

Basic

 

30,614

 

30,090

 

30,437

 

29,783

 

Diluted

 

30,614

 

30,686

 

30,934

 

31,249

 

Allocation of stock-based compensation to operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

$

33

 

$

78

 

$

123

 

$

275

 

Selling, general and administrative

 

157

 

43

 

298

 

210

 

 

 

 

 

 

 

 

 

 

 

 

 

$

190

 

$

121

 

$

421

 

$

485

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4



 

MONOLITHIC SYSTEM TECHNOLOGY, INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

(Unaudited)

 

(In thousands)

 

 

 

Nine Months Ended
September 30,

 

 

 

2003

 

2002

 

Cash flows from operating activities:

 

 

 

 

 

Net income

 

$

2,923

 

$

8,261

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Depreciation and amortization

 

1,533

 

858

 

Amortization of deferred stock-based compensation

 

421

 

485

 

Interest income on notes receivable from stockholder

 

 

(7

)

Changes in current assets and liabilities:

 

 

 

 

 

Accounts receivable

 

6

 

(1,213

)

Unbilled contract receivable

 

(511

)

(230

)

Inventories

 

445

 

452

 

Prepaid expenses and other assets

 

(605

(1,962

)

Deferred revenue

 

(1,453

)

(2,055

)

Accounts payable

 

(21

)

(751

Accrued liabilities

 

512

 

(755

)

Net cash provided by operating activities

 

3,250

 

3,083

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

Purchase of property and equipment

 

(460

)

(1,171

)

Payment of capital lease obligations

 

(84

)

 

Purchase of available-for-sale investments

 

(156,772

)

(150,690

)

Proceeds from maturity of short-term investments

 

191,702

 

128,228

 

Acquisition of business and related expenses, net of cash acquired

 

 

(11,955

)

Purchase of long-term investments

 

(36,902

)

 

Net cash used in investing activities

 

(2,516

)

(35,588

)

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Payment of note receivable from shareholder

 

 

246

 

Proceeds from issuance of common stock

 

1,810

 

726

 

Net cash provided by financing activities

 

1,810

 

972

 

Net increase (decrease) in cash and cash equivalents

 

2,544

 

(31,533

)

Cash and cash equivalents at beginning of period

 

26,321

 

47,363

 

Cash and cash equivalents at end of period

 

$

28,865

 

$

15,830

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5



 

MONOLITHIC SYSTEM TECHNOLOGY, INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

Note 1. Background and Basis of Presentation

 

The Company

 

Monolithic System Technology, Inc. (the “Company” or “MoSys”) was incorporated in California on September 16, 1991 to design, develop and market high performance semiconductor memory products and technologies used by the semiconductor industry and electronic product manufacturers. On September 12, 2000, the shareholders approved the Company’s reincorporation in Delaware.

 

The Company has developed an innovative embedded-memory technology, called 1T-SRAM, which the Company licenses worldwide on a non-exclusive basis to semiconductor companies and electronic products manufacturers. Through 1998, the Company focused primarily on the sale of stand-alone memory products. In the fourth quarter of 1998, the Company changed the emphasis of its business model to focus primarily on the licensing of its 1T-SRAM technology.

 

The accompanying condensed consolidated financial statements of the Company have been prepared without audit in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted in accordance with these rules and regulations. The information in this report should be read in conjunction with the Company’s financial statements and notes thereto included in its most recent annual report on Form 10-K filed with the Securities and Exchange Commission.

 

In the opinion of management, the accompanying unaudited condensed financial statements reflect all adjustments (consisting only of normal recurring adjustments) necessary to summarize fairly the Company’s financial position, results of operations and cash flows for the interim periods presented. The operating results for the three-month and nine-month periods ended September 30, 2003 are not necessarily indicative of the results that may be expected for the year ending December 31, 2003 or for any other future period.

 

Basis of Presentation

 

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation. The Company reports financial results on a calendar fiscal year.  Certain amounts reported in previous quarters have been reclassified to conform the current presentation.

 

Use of estimates

 

The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates.

 

We believe that the following accounting policies are affected by estimates and judgments including those described below:

 

Revenue. If a licensing contract involves performance specifications that we have significant experience in meeting and the cost of contract completion can be reasonably estimated, we recognize the revenue over the period in which the contract services are performed using the percentage of completion method. We follow this method because we can obtain reasonably dependable estimates of the costs to perform the contracted services. Labor costs for the development of the licensee’s design are estimated at the beginning of the contract. As these costs are incurred, they are used as a measure of progress towards completion. We have the ability to reasonably estimate labor cost on a contract-to-contract basis from our previous experience in developing designs for other licensees. During the contract performance period we review estimates of cost to complete the contract as the contract progresses to completion and will revise our estimates of revenue and gross profit under the contract if we revise the estimations of the cost to complete. Our policy is to reflect any revision in the contract gross profit estimate in reported income for the period in which the facts giving rise to the revision

 

6



 

become known. There were no significant changes in estimates of costs to complete contracts during the three-month or nine-month periods ended September 30, 2003.

 

Inventory.  We state inventories at the lower of cost or market, determined using the first-in, first-out method. Our policy is to write down our inventory for estimated obsolescence or unmarketable inventory to the extent the cost exceeds the estimated market value. We base the estimate on our historical sales within six months of the end of the relevant period and current market conditions. If actual market conditions are less favorable than those assumed in our estimates, additional inventory write-downs may be required. Our policy is to reflect any write-down of inventory in reported income for the period in which the facts giving rise to the inventory write-down become known.

 

Impairment of Goodwill.  According to our accounting policy, we performed an annual review of goodwill recorded from the acquisition of ATMOS in August 2002. During the fourth quarter of 2002, we found no impairment based on the undiscounted cash flows test. We will perform the annual impairment test in the third quarter of each year, or more frequently if indicators of potential impairment exist. Our impairment review process is based on the guidance provided in SFAS No. 142, which utilizes a discounted future cash flow.  This approach uses our estimates of revenue for the enterprise, driven by assumed market growth rates and assumed market segment share, and estimated costs as well as appropriate discount rates. Changes in our estimate could result in substantial charges for impairment of goodwill.    We performed the annual impairment test during the third quarter of 2003 and the test did not indicate impairment of goodwill as of September 30, 2003

 

Tax valuation allowance. When we prepare our consolidated financial statements, we estimate our income tax liability for each of the various jurisdictions where we conduct business. This requires us to estimate our actual current tax exposure and to assess temporary differences that result from differing treatment of certain items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which we show on our consolidated balance sheet under the category of other current assets. The net deferred tax assets are reduced by a valuation allowance if, based upon weighted available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. When we establish a valuation allowance or increase this allowance in an accounting period, we must record a tax expense in our statement of operations. Management must make significant judgments to determine our provision for income taxes, our deferred tax assets and liabilities and any valuation allowance to be recorded against our net deferred tax asset. As of December 31, 2002, we had net operating loss carryforwards of approximately $2.5 million for federal tax purposes that we expect to be available to reduce our current year taxable income and effective tax rate.

 

Foreign Currency Translation

 

The Company has foreign offices located in Canada, Korea and Japan, which are operated by subsidiaries of the Company.  The functional currency of the Company’s foreign entities is the U.S. dollar. Accordingly, the financial statements of these entities, which are maintained in the local currency, are remeasured into U.S. dollars in accordance with Statement of Financial Accounting Standards No. 52, “Foreign Currency Translation.” Exchange gains or losses from remeasurement of monetary assets and liabilities that are not denominated in U.S. dollar were not material for any period presented and are included in the consolidated income statements.

 

Cash Equivalents, Short-term and Long-term Investments

 

The Company accounts for investments in accordance with Statement of Financial Accounting Standards No. 115 “Accounting for Certain Investments in Debt and Equity Securities”. Management determines the appropriate classification of debt securities at the time of purchase. The Company’s short-term and long-term investments are carried at fair value, based on quoted market prices, with unrealized holding gains and losses reported in stockholders’ equity. Realized gains and losses and declines in the value judged to be other-than-temporary are included in interest income. The cost of securities sold is based on the specific identification method.

 

The Company invests its excess cash in money market accounts and debt instruments, including U.S. government bonds and corporate notes, and considers all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents. Investments with original maturities greater than three months and remaining maturities less than one year are classified as short-term investments.  Investments with remaining maturities greater than one year are classified as long-term investments.

 

Property and equipment

 

Property and equipment are stated at cost. Depreciation is generally computed using the straight-line method over the estimated useful lives of the assets, generally three years.

 

7



 

Goodwill

 

Goodwill represents the excess acquisition cost over the fair value of tangible and identified intangible net assets acquired. Effective January 1, 2002, in conjunction with the implementation of SFAS No. 142, all goodwill, including goodwill related to

acquisitions prior to July 1, 2001, is no longer amortized and potential impairment of goodwill and purchased intangible assets with indefinite useful lives are evaluated using the specific guidance provided by SFAS No. 142. This impairment analysis is performed at least annually.  Under SFAS 142, “Goodwill and Other Intangible Assets”, the Company reviews goodwill annually or more frequently, if impairment indicators arise based on the undiscounted cash flow test.  The impairment review process is based on a discounted future cash flow approach that uses our estimates of revenue for the enterprise, driven by assumed market growth rates and assumed market segment share, and estimated costs as well as appropriate discount rates. In the event such cash flows are not expected to be sufficient to recover the recorded value of goodwill, it is written down to its estimated fair value based on discounted cash flows.

 

Revenue recognition

 

Product

 

The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable and collection is probable. The terms of all product sales are FOB shipping point. The Company’s sales agreements do not provide for any customer acceptance provisions. The Company has no obligation to provide any modification, customization, upgrades, enhancements, post-contract customer support or additional products. Allowances for sales return or warranty liabilities are recorded based upon historical experience and any specific known pending customer returns. There are no rights of return unless the product does not perform according to specifications. Provisions for estimated returns, and to a lesser degree potential warranty liability, are recorded when revenue is recognized.

 

Licensing

 

Licensing revenue consists of fees paid for engineering development and engineering support services. All contracts we have entered into to date require that the Company develop a design that meets the licensee’s specifications. For contracts involving design specifications that the Company has not previously met, the Company defers the recognition of revenue until the design meets the contractual design specifications and expenses the cost of services as incurred. When the Company has experience in meeting the design specifications but does not have sufficient experience to reasonably estimate the cost of services to meet the design specification, the Company defers both the recognition of revenue and the cost. For these arrangements, the Company recognizes revenue using the completed contract method. However, if the Company has significant experience in meeting the design specification involved in the contract and the cost of services under the contract can be reasonably estimated, the Company recognizes revenue over the period in which the contract services are performed. For these arrangements, the Company recognizes revenue using the percentage of completion method. Labor costs for the development of the licensee’s design are estimated at the beginning of the contract. As these costs are incurred, they are used as a measure of progress towards completion. The Company has the ability to reasonably estimate labor cost on a contract-by-contract basis based on its prior experience in developing licensees’ designs.

 

From time to time, a licensee may cancel a project during the development phase. The Company has no control over the cancellation, which is often caused by changes in market conditions or the licensee’s business. Contract cancellations are an aspect of the Company’s licensing business, and the Company’s contracts allow it to retain all payments that it receives or is entitled to collect for services provided before the cancellation occurs. The Company’s revenue recognition policy states that a project be considered canceled even in the absence of specific notice from its licensee if there has been no activity under the contract for six months, and the Company believes that completion of the contract is unlikely. In this event, the Company recognizes revenue equal to the amount of cash received, if it has performed the development services, for which the cash was received.  For the third quarter of 2003, we recognized no licensing revenue from cancelled projects compared to $275,000 in the same period of 2002. For the first nine months ended September 30, 2003, we recognized $700,000 of licensing revenue from cancelled projects compared to $804,000 in the corresponding period of 2002.

 

Royalty

 

The Company’s licensing contracts provide also for royalty payments at a stated rate and require licensees to report the manufacture or sale of products that include the Company’s technology after the end of the quarter in which the sale or manufacture occurs. The Company recognizes royalties in the quarter in which the Company receives the licensee’s report.

 

Advertising

 

Advertising costs are expensed as incurred and are not material.

 

8



 

Cost of revenue

 

Product

 

Cost of product revenue consists primarily of costs associated with the manufacture, assembly and testing of our memory chip products by independent, third-party contractors.

 

Licensing

 

Cost of licensing revenue consists primarily of engineering costs directly related to engineering development projects specified in agreements between the Company and the licensees of its 1T-SRAM technologies. These projects typically include customization of circuitry to enable the embedding of our 1T-SRAM technologies on a licensee’s integrated circuit and may include engineering support to assist in the commencement of production of a licensee’s products. If licensing revenue is recognized using the percentage of completion method, the associated cost of licensing revenue is recognized in the period in which the Company incurs the engineering cost. If licensing revenue is recognized using the completed contract method, and to the extent that the amount of engineering costs does not exceed the amount of the related licensing revenues, such costs are deferred on a contract-by-contract basis once the Company has established technological feasibility of the product to be developed under the license. Technological feasibility is established when the Company has completed all activities necessary to demonstrate that the licensee’s product can be produced to meet the performance specifications when incorporating our technology. Deferred costs are charged to cost of licensing revenue when the related revenue is recognized, and until then, are included in prepaid and other current assets. However, for contracts entered into prior to establishing technological feasibility, the Company does not defer related development costs, but rather records them as research and development expenses in the period they are incurred. Consequently, upon completion of such contracts, the Company recognizes the revenue earned under them without any corresponding costs.

 

Royalty

 

There are no reported costs associated with royalty revenue.

 

Research and development

 

Research and development costs are expensed as incurred. These include costs related to contract services for projects as to which we have not established technological feasibility.

 

Stock-based compensation

 

The Company accounts for stock-based compensation arrangements in accordance with the provisions of APB No. 25 (“APB No. 25”), “Accounting for Stock Issued to Employees” and complies with the disclosure provisions of Statement of Financial Accounting Standard No. 123 (“SFAS No. 123”), “Accounting for Stock-Based Compensation”, as amended by SFAS No. 148 “Accounting for Stock-Based Compensation-Transition and Disclosure” (“SFAS No. 148”).

 

Under APB No. 25, compensation cost is, in general, recognized based on the excess, if any, of the fair market value of the Company’s stock on the date of grant over the amount an employee must pay to acquire the stock. Equity instruments issued to non-employees are accounted for in accordance with the provisions of SFAS No. 123 and Emerging Issues Task Force 96-18, “Accounting for Equity Instruments That Are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods or Service”. Deferred stock-based compensation is being amortized using the graded vesting method in accordance with Financial Accounting Standards Board Interpretation No. 28 (“FIN No. 28”), “Accounting for Stock Appreciation Rights and Other Variable Stock Option or Award Plans (an interpretation of APB Opinions No. 15 and 25)” over the vesting period of each respective option, which is generally four years.  Under the graded vesting method, each option grant is separated into portions based on its vesting terms, which results in acceleration of amortization expense for the overall award compared to the straight line method.

 

SFAS No. 123 pro forma disclosures as required by SFAS No. 148

 

Had compensation expense for the Company’s option plans been determined based on the fair value at the grant dates, as prescribed in SFAS No. 123, the Company’s net income would have been as follows (in thousands, except per share amounts):

 

9



 

 

 

Three months ended

 

Nine months ended

 

 

 

September 30,
2003

 

September 30,
2002

 

September 30,
2003

 

September 30,
2002

 

 

 

 

 

 

 

 

 

 

 

Net Income (loss):

 

 

 

 

 

 

 

 

 

As reported

 

$

(249

)

$

2,756

 

$

2,923

 

$

8,261

 

Stock-based compensation expense reported in statement of operations

 

44

 

121

 

179

 

485

 

Total stock-based compensation expense determined under fair value based method for all awards, net of related tax effects

 

1,351

 

915

 

3,434

 

2,047

 

Pro forma

 

$

(1,556

)

$

1,962

 

$

(332

)

$

6,699

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic—as reported

 

$

(0.01

)

$

0.09

 

$

0.10

 

$

0.28

 

Basic—pro forma

 

$

(0.05

)

$

0.07

 

$

(0.01

)

$

0.22

 

Diluted—as reported

 

$

(0.01

)

$

0.09

 

$

0.09

 

$

0.26

 

Diluted—pro forma

 

$

(0.05

)

$

0.06

 

$

(0.01

)

$

0.21

 

 

 

The fair value of each grant is estimated on the date of grant using the Black-Scholes method with the following assumptions used for grants during the applicable periods:

 

 

 

For the three months
ended September 30,

 

For the nine months
ended September 30,

 

Employee stock options

 

2003

 

2002

 

2003

 

2002

 

Expected life (in years)

 

5.0

 

5.0

 

5.0

 

5.0

 

Risk-free interest rate

 

3.0%-3.6

%

3.2%-3.9

%

2.1%-3.6

%

3.2%-4.7

%

Volatility

 

0.8

 

0.8

 

0.8

 

0.7

 

Dividend yield

 

0

%

0

%

0

%

0

%

 

Stock Participation Plan shares

 

2003

 

2002

 

2003

 

2002

 

Expected life (in years)

 

1.0

 

1.0

 

1.0

 

1.0

 

Risk-free interest rate

 

1.1

 

2.1

 

1.1%-1.4

%

2.1%-2.3

%

Volatility

 

0.8

 

0.8

 

0.8

 

0.6

 

Dividend yield

 

0

0

0

%

0

%

 

The Company selected the Black-Scholes option valuation model, which is one of the permitted methods to estimate the fair market value of options under SFAS No. 123.  Under this valuation model, the weighted average fair value of options granted for the three months ended September 30, 2003 and 2002 was $5.12 and $4.35, respectively, and for the nine months ended September 30, 2003 and 2002 was $4.98 and $4.26, respectively. The weighted average estimated fair value of shares granted under the employee stock purchase plan for the three months ended September 30, 2003 and 2002 was $4.65 and $4.05 respectively, and for the nine months ended September 30, 2003 and 2002 was $4.21 and $4.05, respectively. 

 

The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. Option valuation models like Black-Scholes require the input of highly subjective assumptions, including the expected stock price volatility. Because the Company’s employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimated, in the opinion of management, the existing models do not necessarily provide a reliable single measure of the fair value of employee stock options.

 

Net income (loss) per share

 

Basic net income (loss) per share is computed by dividing net income (loss) for the period by the weighted-average number of shares of common stock outstanding during the period. Diluted net income (loss) per share is computed by dividing the net income (loss) available to common stockholders for the period by the weighted average number of common and potential common equivalent shares outstanding during the period. Potential common equivalent shares are composed of incremental shares of common stock

 

10



 

issuable upon the exercise of stock options and warrants.  For the three months ended September 30, 2003, outstanding employee stock options of 803,000 shares were not included in the calculation of diluted net income (loss) per share as they were anti-dilutive.

 

The following table presents the calculation of basic and diluted income (loss) per share (in thousands, except per share amounts):

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

 

2003

 

2002

 

2003

 

2002

 

Numerator:

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(249

$

2,756

 

$

2,923

 

$

8,261

 

Denominator:

 

 

 

 

 

 

 

 

 

Shares used in computing net income (loss) per share:

 

 

 

 

 

 

 

 

 

Basic

 

30,614

 

30,090

 

30,437

 

29,783

 

Employee stock options and unvested common stock outstanding

 

 

596

 

497

 

1,079

 

Warrants

 

 

 

 

387

 

Preferred stock

 

 

 

 

 

Diluted

 

30,614

 

30,686

 

30,934

 

31,249

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.01

$

0.09

 

$

0.10

 

$

0.28

 

Diluted

 

$

(0.01

$

0.09

 

$

0.09

 

$

0.26

 

 

Income taxes

 

The Company accounts for deferred income taxes under the liability approach whereby the expected future tax consequences of temporary differences between the book and tax basis of assets and liabilities are recognized as deferred tax assets and liabilities. A valuation allowance is established for any deferred tax assets for which realization is uncertain.

 

Comprehensive income

 

Statement of Financial Accounting Standards No. 130 “Reporting Comprehensive Income” (“SFAS No. 130”) requires the Company to display comprehensive income and its components as part of the financial statements. The Company’s only component of comprehensive income is unrealized gains and losses on available for sale securities.  Accumulated other comprehensive income, as of September 30, 2003 and December 31, 2002 was $114,000 and $116,000, respectively.

 

The changes in other comprehensive income (loss), net of taxes, were as follows, for the three months and nine months ended September 30, 2003 and 2002 respectively:

 

 

 

Three months ended
September 30,

 

Nine months ended
September 30,

 

 

 

2003

 

2002

 

2003

 

2002

 

Net income (loss)

 

$

(249

$

2,756

 

$

2,923

 

$

8,261

 

Net unrealized gain (loss) on available-for-sale securities:

 

 

 

 

 

 

 

 

 

Change in net unrealized gains(losses)

 

 

19

 

(2

)

98

 

 

 

 

 

 

 

 

 

 

 

Comprehensive income (loss)

 

$

(249

$

2,775

 

$

2,921

 

$

8,359

 

 

Segment reporting

 

Financial Accounting Standards Board Statement No. 131, “Disclosure about Segments of an Enterprise and Related Information” (“SFAS No. 131”) requires that companies report separately in the financial statements certain financial and descriptive information about operating segments profit or loss, certain specific revenue and expense items and segment assets. The Company operates in one segment, using one measurement of profitability for its business. The Company has sales outside the United States that are described in Note 5. The majority of long-lived assets are maintained in the United States.

 

11



 

Recent accounting pronouncements

 

Statement of Financial Accounting Standards (SFAS) No. 146, “Accounting for Costs Associated with Exit or Disposal Activities” (“SFAS No. 146”), requires the Company to recognize costs associated with exit or disposal activities when they are incurred rather than at the date of commitment to an exit or disposal plan. SFAS No. 146 replaces Emerging Issues Task Force (EITF) Issue No. 94-3, “Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring).” The provisions of SFAS No. 146 are to be applied prospectively to exit or disposal activities initiated after December 31, 2002. The effect of adoption of SFAS No. 146 is dependent on the Company’s related activities subsequent to the date of adoption.  There were no restructuring activities during the nine months ended September 30, 2003.

 

In November 2002, the Financial Accounting Standards Board (FASB) issued FASB Interpretation No. 45, “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others” (“FIN No. 45”). FIN No. 45 requires that upon issuance of a guarantee, a guarantor must recognize a liability for the fair value of an obligation assumed under a guarantee. FIN No. 45 also requires additional disclosures by a guarantor in its interim and annual financial statements about the obligations associated with guarantees issued. The recognition provisions of FIN No. 45 are effective for any guarantees issued or modified after December 31, 2002. The disclosure requirements are effective for financial statements of interim or annual periods ending after December 15, 2002. The adoption of FIN No. 45 did not have a material effect on the Company’s financial position, results of operations, or cash flows.  See Note 4, “Guarantees”.

 

In January 2003, the Financial Accounting Standards Board (FASB) issued Interpretation No. 46, “Consolidation of Variable Interest Entities” (“FIN No. 46”).  FIN No. 46 requires consolidation of variable interest entities (VIE) by the entity’s primary beneficiary if the entity’s equity investors do not have characteristics of a controlling financial interest or sufficient equity at risk.  FIN No. 46 is effective immediately for all new VIEs created or acquired after January 31, 2003.  As amended by FASB Staff Position No. FIN No. 46-6, FIN No. 46 is effective for variable interests in a VIE created or acquired before February 1, 2003 at the end of the first interim or annual period ending after December 15, 2003. FIN No. 46 requires certain disclosures in financial statements issued after January 31, 2003, if it is reasonably possible that the Company will consolidate or disclose information about VIEs when FIN No. 46 becomes effective.  The Company has not invested in any VIEs created after January 31, 2003.

 

In April 2003, the FASB issued Statement of Financial Accounting Standards No. 149, “Amendment of Statement 133 on Derivative Instruments and Hedging Activities” (“SFAS No. 149”) which amends and clarifies accounting for derivative instruments and hedging activities under SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities” (“SFAS No. 133”).  SFAS No. 149 provides guidance relating to decisions made (a) as part of the Derivatives Implementation Group process, (b) in connection with other FASB projects dealing with financial instruments and (c) regarding implementation issues raised in the application of the definition of a derivative and the characteristics of a derivative that contains financing components.  SFAS No. 149 is effective for contracts entered into or modified and for hedging relationships designated after June 30, 2003.  The adoption of SFAS No. 149 did not have a material impact on the Company’s financial condition or results of operations for the nine months ended September 30, 2003 as the Company has not entered into any derivative instruments.

 

In May 2003, the FASB issued SFAS No. 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity” (“SFAS No. 150”) which requires freestanding financial instruments such as mandatorily redeemable shares, forward purchase contracts and written put options to be reported as liabilities by their issuers as well as related new disclosure requirements.  The provisions of SFAS No. 150 are effective for instruments entered into or modified after May 31, 2003 and pre-existing instruments as of the beginning of the first interim period that commences after June 15, 2003.  The adoption of SFAS No. 150 did not have a material impact on the Company’s financial condition or results of operations for the three or nine months ended September 30, 2003.

 

In November 2002, the EITF reached a consensus on Issue No. 00-21, “Revenue Arrangements with Multiple Deliverables” (“EITF Issue No. 00-21”). EITF Issue No. 00-21 provides guidance on how to account for arrangements that involve the delivery or performance of multiple products, services and/or rights to use assets. The provisions of EITF Issue No. 00-21 will apply to revenue arrangements entered into in fiscal periods beginning after June 15, 2003. The adoption of EITF Issue No. 00-21 did not have a material effect on the Company’s financial position, results of operations, or cash flows for the third quarter ended September 30, 2003.

 

Note 2—Acquisition

 

Acquisition of ATMOS Corporation

 

On August 30, 2002, the Company completed the acquisition of 100% of the outstanding stock of ATMOS Corporation, a semiconductor memory company focused on creating high-density, compiler-generated embedded memory solutions for System-on-a-Chip (“SoC”) applications. The total purchase price for the acquisition was approximately $12.4 million, including direct transaction costs of $406,000. The consideration paid to ATMOS shareholders consisted of a combination of $11.7 million in cash and 26,843 shares of common stock issued to certain ATMOS employees, with a combined total fair value of $12.0 million. Under the purchase method of accounting the common stock was valued at $11.47 per share using the Company’s average stock price for a five-day

 

12



 

period consisting of two days before, the day of and two days after June 10, 2002, the announcement date on which the number of shares to be issued was fixed. The Company loaned $500,000 to ATMOS under a promissory note due on July 31, 2002, which became non-refundable upon completion of the acquisition, and has been included in the cash portion of the purchase price.

 

In addition, the Company issued 34,900 shares of common stock subject to a 36-month vesting period and paid cash of $153,000 to ATMOS continuing employees in exchange for outstanding stock of ATMOS. The shares and cash are subject to forfeiture in the event that the employees cease to be employed by MoSys, and consequently are being accounted for as compensation rather than acquisition cost. The Company recorded approximately $314,000 of unearned compensation related to the shares subject to vesting, which will be amortized over the vesting period using the graded vesting method. The cash portion was amortized over 12 months following the closing date.

 

Since August 30, 2002, ATMOS has been a wholly owned subsidiary of the Company.  The acquisition has been accounted for as a purchase.  The accompanying financial statements include the results of operations of ATMOS subsequent to the acquisition date. The purchase price has been allocated to the tangible assets acquired based on management’s estimate of their fair values, and to the intangible assets acquired based on their estimated fair values as determined by an independent appraisal. The purchase price allocation was as follows (in thousands):

 

Tangible assets acquired:

 

 

 

Cash

 

$

84

 

Prepaids and other assets

 

390

 

Fixed Assets

 

1,643

 

Total tangible assets

 

2,117

 

Total liabilities acquired

 

2,002

 

Intangible assets acquired:

 

 

 

Net tangible assets acquired

 

115

 

Goodwill

 

12,326

 

Total purchase price allocation

 

$

12,441

 

 

Goodwill will be reviewed annually for impairment based on estimated future undiscounted cash flows attributable to goodwill, or more frequently, if impairment indicators arise. In the event such cash flows are not expected to be sufficient to recover the recorded value of goodwill, it will be written down to its estimated fair value based on undiscounted cash flows. The Company believes that as of September 30, 2003, there were no impairment indicators regarding goodwill; therefore, no such charges have been recorded for the period ended September 30, 2003. For income tax purposes, the entire amount of goodwill is amortized and deducted ratably over 15 years.

 

At the closing of the acquisition, an escrow account was established to satisfy any unidentified claims against ATMOS.  The amount held in escrow, net of claims recovered by the Company, was released to the ATMOS shareholders in October 2003.

 

Unaudited Pro Forma Information

 

The following unaudited pro forma information presents the consolidated result of operations of the Company, as if the acquisition of ATMOS had occurred at the beginning of the period presented. The pro forma result of operations combines the consolidated results of operations of the Company for the three months and nine months ended September 30, 2002 with the historical results of operations of ATMOS for the three months and nine months ended September 30, 2002, respectively. The pro forma adjustments in the three months and nine months ended September 30, 2002 include $38,000 and $115,000 of cash compensation paid subject to forfeiture and $49,000 and $147,000 of stock compensation expenses associated with shares issued subject to forfeiture, respectively. Unearned compensation of $314,000 has been amortized using the graded method over the vesting period of three years, which results in the amortization of approximately 62% in the first year. The unaudited pro forma information does not purport to be indicative of what would have occurred had the acquisition been made as of the beginning of the period presented or of results which may occur in the future.

 

13



 

 

 

Three months ended
September 30, 2002

 

Nine months ended
September 30, 2002

 

 

 

(In thousands except per share amounts)

 

 

 

 

 

 

 

Revenues

 

$

7,011

 

$

19,976

 

Net income

 

1,053

 

3,427

 

Net income per share:

 

 

 

 

 

Basic

 

$

0.03

 

$

0.11

 

 

 

 

 

 

 

Diluted

 

$

0.03

 

$

0.11

 

 

 

 

 

 

 

Shares used in computing net income per share

 

 

 

 

 

Basic

 

30,152

 

29,845

 

Diluted

 

30,748

 

31,426

 

 

Note 3. Inventories

 

Inventories consist of the following (in thousands):

 

 

 

September 30,
2003

 

December 31,
2002

 

 

 

 

 

 

 

Work-in-process

 

$

307

 

$

477

 

Finished goods

 

285

 

560

 

 

 

$

592

 

$

1,037

 

 

Note 4. Guarantees

 

Product Warranties:

 

The Company generally offers a 90-day warranty for its memory chip products. The Company provides reserves for the estimated costs of product warranties at the time revenue is recognized. The Company estimates the costs of its warranty obligations based on its historical experience of replacement costs incurred for the last 90 days in correcting product failures.  The Company has not experienced any material issues regarding warranty.  The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary. Accordingly, the Company assessed the level of warranty reserve as of September 30, 2003 and determined that no warranty reserve was necessary.  The Company does not have any other guarantees as of September 30, 2003.

 

From time to time, the Company enters into contracts with licensees of its 1T-SRAM technologies in which the Company provides some indemnification to the licensee in the event of claims of patent or other intellectual property infringement resulting from the licensee’s use of the licensed technology.  Such provisions are customary in the semiconductor industry and do not reflect an assessment by the Company of the likelihood of a claim.  The Company has not recorded a liability for potential obligations under these indemnification provisions and would not record such a liability unless the Company believed that the likelihood of a material obligation was probable.  See Note 6, “Contingencies.”

 

Note 5. Segment Information

 

The Company operates in a single industry segment, supplying semiconductor memories to the electronics industry. The Company sells its products and technology to customers in the Far East, North America and Europe. Net revenue by geographic area was (in thousands):

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

 

2003

 

2002

 

2003

 

2002

 

 

 

 

 

 

 

 

 

 

 

United States

 

$

1,654

 

$

2,279

 

$

6,342

 

$

6,960

 

Japan

 

1,288

 

3,090

 

6,248

 

8,837

 

Other Asian Countries

 

459

 

1,395

 

2,942

 

3,475

 

Europe

 

98

 

247

 

350

 

664

 

Total

 

$

3,499

 

$

7,011

 

$

15,882

 

$

19,936

 

 

A few customers account for a significant percentage of our total revenue. For the quarter ended September 30, 2003, Sony, Marvel and Motorola represented 28%, 11% and 11% of total revenue, respectively.  In the third quarter of 2002, two customers, NEC and UMC, represented 40% and 15% of our total revenue, respectively.  For the nine months ended September 30, 2003, three customers, NEC, Sony and UMC represented 17%, 17% and 13% of total revenue, respectively.  In the first nine months of 2002, NEC, Nintendo and UMC represented 33%, 10% and 10% of total revenue, respectively.  Historically, a substantial portion of our

 

14



 

revenues has been derived from the royalties from the licenses of integrated circuits used by Nintendo in its Gamecube video game console.  Gamecube-related revenue represented 0% and 34% of total revenue in the third quarter ended September 30, 2003 and 2002, respectively. Gamecube-related revenue represented 13% and 40% of total revenue in the first nine months of 2003 and 2002, respectively.  A decline in Gamecube-related revenue for the three months and nine months ended September 30, 2003 was due to a reduction in Nintendo’s purchase of chips incorporating our licensed technology for its Gamecube consoles.

 

Note 6. Contingencies

 

From time to time, the Company may be subject to legal proceedings and claims in the ordinary course of business.  These claims, even if not meritorious, could result in the expenditure of significant financial and other resources.  The Company is not currently aware of any legal proceedings or claims, and management does not believe that the Company is subject to claims that would constitute material contingencies.

 

Note 7. Capital lease obligations

 

The Company assumed capital lease obligations through the acquisition of ATMOS. Equipment under capital lease arrangements included in property and equipment aggregated approximately $176,000 at September 30, 2003. Related accumulated depreciation was approximately $149,000 at September 30, 2003.

 

Future minimum lease payments under capital leases as of September 30, 2003 are as follows (in thousands):

 

Remainder of 2003

 

$

6

 

2004

 

14

 

2005

 

13

 

2006

 

 

 

 

 

 

Total minimum payments

 

33

 

Less amount representing interest

 

3

 

 

 

30

 

Less current portion

 

14

 

Long term portion

 

$

16

 

 

Note 8. Provision for Income Taxes

 

The Company’s provision for income taxes for the nine months ended September 30, 2003 and 2002 was $325,000 and $2.1 million, respectively. The effective income tax rate was 10% and 20% for the nine months ended September 30, 2003 and 2002, respectively. The effective rates were lower than the U.S. federal and state combined statutory rate primarily due to the utilization of net operating losses and research and development credits that were previously reserved.

 

The Company’s effective tax rate is based on the estimated annual effective tax rate in accordance with Statement of Financial Accounting Standards No. 109 “Accounting for Income Taxes”.   A benefit for income taxes of  $468,000 was recorded in the third quarter of 2003 due to a reduction in the annual effective income tax rate to 10% from 20% for 2003.  The effective tax rate was reduced primarily due to the impact of reductions in projected profits before tax on anticipated benefits from net operating losses and research and development credits. The provision of income taxes was  $689,000 and the effective tax rate was 20% in the same period 2002. The effective rates were lower than the U.S. federal and state combined statutory rate primarily due to the utilization of net operating losses and research and development credits that were previously reserved.

 

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

This Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the accompanying condensed consolidated financial statements and notes included in this report. This Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which include, without limitation, statements about the market for our technology, our strategy, competition, expected financial performance, all information disclosed under Item 3 of this Part I., and other aspects of our business identified in the Company’s most recent annual report on Form 10-K filed with the Securities and Exchange Commission and in other reports that we file from time to time with the Securities and Exchange Commission. Any statements about our business, financial results, financial condition and operations contained in this Form 10-Q that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “expects,” “intends,” “projects,” or similar expressions are intended to identify forward-looking statements. Our actual results could differ materially from those expressed or implied by these forward-looking statements as a result of various factors, including the risk factors described in Risk Factors and

 

15



 

elsewhere in this report. We undertake no obligation to update publicly any forward-looking statements for any reason, except as required by law, even as new information becomes available or events occur in the future.

 

MoSys® and 1T-SRAM® are our trademarks. Product names, trade names and trademarks of other companies are also referred to in this report.

 

Overview

 

We design, develop, license and market memory technologies used by the semiconductor industry and electronic product manufacturers. We have developed a patented semiconductor memory technology, called 1T-SRAM, that offers a combination of high density, low power consumption and high speed at performance and cost levels that other available memory technologies do not match. We license this technology to companies that incorporate, or embed, memory on complex integrated circuits. We also sell memory chips based on our 1T-SRAM technologies. The sale of our 1T-SRAM memory chips supports the future development and marketing of our 1T-SRAM technology to licensees.

 

Using elements of our existing memory technology as a foundation, we completed development of our first memory chips incorporating our 1T-SRAM technologies in the fourth quarter of 1998. We signed our first license agreement related to our 1T-SRAM technologies at the end of the fourth quarter of 1998 and recognized licensing revenue from our 1T-SRAM technologies for the first time in the first quarter of 2000. In late 2001 and 2002, we introduced improved and enhanced versions of the technology, 1T-SRAM-R, 1T-STRAM-M, and 1T-SRAM-Q.

 

We generate revenue from intellectual property licensing, which consists of licensing revenue and royalty revenue. Our licensing revenue consists of fees paid for engineering development and engineering support services. We are entitled to receive royalties under each of our licensing agreements when our licensees manufacture or sell products that incorporate our technology.

 

As of September 30, 2003, we had signed license agreements related to our 1T-SRAM technologies with 37 companies. Generally, we expect our total sales cycle, or the period from our initial discussion with a prospective licensee to our receipt of royalties from the licensee’s use of our 1T-SRAM technologies, to run from 18 to 24 months.

 

On August 30, 2002, we completed the acquisition of 100% of the outstanding stock of ATMOS Corporation. ATMOS is a semiconductor memory company that focuses on creating high-density, compiler-generated embedded memory solutions for SoC applications. The total purchase price for the acquisition was approximately $12.4 million including direct transaction costs of $406,000. The consideration paid to ATMOS shareholders consisted of $11.7 million in cash and 26,843 shares of our common stock issued to certain ATMOS employees for a combined total fair value of $12.0 million.  The results of operations of ATMOS are included in the Company’s financial statements from the date of acquisition.

 

Revenue.  We generate three types of revenue: license fees, royalties and product sales. Prior to 2001, we derived almost all our revenue from the sale of memory chips. Since the beginning of 2001, product revenue as a percentage of total revenue has declined significantly, while license fees and royalties have grown as a percentage of total revenue. In the third quarter of 2001, for the first time, combined license and royalty revenue exceeded product revenue. We expect this trend to continue for the foreseeable future. Moreover, we anticipate that product revenue will remain weak for the remainder of 2003.

 

Licensing.   Our license agreements involve long sales cycles, which makes it difficult to predict when the agreements will be signed and when, if ever, we will recognize revenues under the agreements. Our licensing revenue will fluctuate from period to period, and, it will be difficult for us to predict the timing and magnitude of such revenue from quarter-to-quarter. Moreover, we believe that the amount of licensing revenues for any period is not necessarily indicative of results in any future period. Our future revenue results are subject to a number of factors, particularly those described in “Risk Factors,” below.

 

Our licensing revenue consists of fees for providing circuit design, layout and design verification support to a licensee that is embedding our memory technology into its product. For some licensees, we also provide engineering support services to assist in the commencement of production for their products utilizing 1T-SRAM technologies. License fees range from less than hundred thousand dollars to several million dollars per contract, depending on the scope and complexity of the development project, the licensee’s rights and the royalties expected to be received under the agreement. The licensee generally pays the license fees in installments at the beginning of the license and upon the attainment of specified milestones. All contracts entered into to date require us to meet performance specifications. For contracts involving performance specifications that we have not met and for which we lack the historical experience to reasonably estimate the costs, we defer recognition of revenue until the licensee manufactures products that meet the contract performance specifications and recognize revenue under the completed contract accounting method. Fees collected prior to revenue recognition are recorded as deferred contract revenue. However, if the contracts involve performance specifications that we have significant experience in meeting and the cost of contract completion can be reasonably estimated, we recognize revenue over the period in which the contract services are performed under the percentage of completion accounting method. Labor costs incurred are used to measure progress towards completion. Under the percentage of completion accounting method, if the amount of

 

16



 

revenue recognized exceeds the amount of billings to a customer, we account for the excess amount as an unbilled contract receivable. This affected our revenue for the first time in the second quarter of 2002. Our total unbilled contract receivable was $1.2 million and $230,000 as of September 30, 2003 and 2002, respectively.

 

Our license agreements are associated with lengthy and complicated engineering development projects, and so the completion of development and commencement of production may be difficult for us to predict. Additionally, from time to time, a licensee may cancel a project during the development phase. The cancellation is not within our control and is often caused by changes in market conditions or the licensee’s business. These cancellations are an aspect of our licensing business, and generally, our contracts allow us to retain all payments that we have received or are entitled to collect for items and services provided before the cancellation occurs. We will consider a project to have been canceled even in the absence of specific notice from our licensee if there has been no activity under the contract for a significant period, and we believe that completion of the contract is unlikely. In this event, we recognize revenue in the amount of cash received, if we have performed a sufficient portion of the development services.  If a cancelled contract was entered into before the technological feasibility was established, the costs associated with the contract would have been expensed prior to the recognition of revenue. Therefore, there would be no costs associated with that revenue recognition, which would increase gross margin for the corresponding period. For the third quarter of 2003, we recognized no licensing revenue from cancelled projects compared to $275,000 in the same period of 2002.  For the first nine months ended September 30, 2003, we recognized $700,000 of licensing revenue from cancelled projects compared to $804,000 in the corresponding period of 2002.

 

Royalties.   Each license agreement provides for royalty payments at a stated rate. We negotiate royalty rates by taking into account such factors as the amount of license fees to be paid, the anticipated volume of the licensee’s sales of products utilizing our technologies and the cost savings to be achieved by the licensee through the use of our technology. Our agreements require the licensee to report the manufacture or sale of products that include our technology after the end of the quarter in which the sale or manufacture occurs. We generally recognize royalties in the quarter in which we receive the licensee’s report. We recorded our first royalty revenue in the quarter ended December 31, 2000. 

 

As with our licensing revenues, the timing and level of royalties are difficult to predict.  They depend on the licensee’s ability to market, produce and sell products incorporating our technology. Many of the products currently subject to licenses from us are consumer products, such as electronic game consoles, for which demand is seasonal and generally highest in the fourth quarter, which we would report in the first quarter of the following year. Furthermore, if a licensee holds excess inventory of products using our licensed technology, we are unlikely to report additional royalty revenue attributable to that product until the quarter after the licensee restarts production. For a discussion of factors that could contribute to the fluctuation of our revenues, please see “Risk Factors—Our lengthy licensing cycle and our licensees’ lengthy development cycles will make the operating results of our licensing business difficult to predict,” and “Anything that negatively affects the business of our licensees could negatively impact our revenue.”

 

Products.   Product sales are typically on a purchase-order basis, with shipment of product occurring from one to six months later. Allowances for sales return or warranty liabilities are recorded based upon historical experiences and any specific known pending customer returns. Currently, Taiwan Semiconductor Manufacturing Co., Ltd., or TSMC, manufactures all of the memory chips that we sell. Our products are assembled and tested prior to shipment by independent, third-party contractors. We contract for manufacturing services on a purchase-order basis and have no long-term commitments for the supply of any of our memory chip products. If we are unable to obtain manufacturing, assembly or testing services required to fill our customer orders for these products, our revenues from these products will decline substantially.

 

Our memory chips are subject to competitive pricing pressure that might result in fluctuating gross profits, which we have experienced in the past. Prior to 1999, we sold most of our memory chips to the personal computer market, which is seasonal, and experienced the strongest demand for these products in the fourth quarter each year. From late 1998 to date, our memory chip sales have consisted primarily of 1T-SRAM chips sold to customers in the communications equipment business, and we have not seen the effect of seasonal demand in the market.

 

The semiconductor industry is currently experiencing a difficult economic environment and downturn. Most of our memory chip sales are made to communications equipment manufacturers, which experienced a sharp economic downturn since 2001. Our product revenues for the third quarter of 2003 were only 65% of our product revenues for the same quarter of last year. We have limited visibility regarding our customer’s chip requirements in 2003 and anticipate further declines in product revenue.

 

Cost of Revenue.  Cost of product revenue consists primarily of costs associated with the manufacture, assembly and testing of our memory chip products by independent, third-party contractors. Cost of licensing revenue consists primarily of engineering costs directly related to engineering development projects specified in agreements we have with licensees of our 1T-SRAM technologies. These projects typically include customization of 1T-SRAM circuitry to enable embedding our memory on a licensee’s integrated circuit and may include engineering support to assist in the commencement of production of a licensee’s products. We recognize costs of licensing revenue in the following manner:

 

17



 

      If licensing revenue is recognized using the percentage of completion method, the associated cost of licensing revenue is recognized in the period in which we incur the engineering expense.

 

      If licensing revenue is recognized using the completed contract method, and to the extent that the amount of engineering cost does not exceed the amount of the related licensing revenue, this cost is deferred on a contract-by-contract basis from the time we have established technological feasibility of the product to be developed under the license. Technological feasibility is established when we have completed all activities necessary to demonstrate that the licensee’s product can be produced to meet the performance specifications when incorporating our technology. Deferred costs are charged to cost of licensing revenue when the related revenue is recognized.

 

      However, for contracts entered into prior to establishing technological feasibility, we do not defer related development costs, but rather expense them in the period in which they are incurred. Consequently, upon completion of these contracts, we recognize the related revenues without any corresponding costs. Furthermore, there are no reported costs associated with royalty revenue.

 

Research and Development.  Research and development expenses consist primarily of salaries and related employee expenses and expenses associated with engineering development software and equipment. Since 1998, our research and development expenses were incurred primarily in support of the design, development and production of customer development projects.

 

Since changing our business model in 1998, we have devoted our research and development efforts primarily to developing our 1T-SRAM technologies and related licensing activities. Research and development expenses can also include development and design of variations of the 1T-SRAM technologies for use in different manufacturing processes used by licensees and the development and testing of prototypes to prove the technological feasibility of embedding our memory designs in the licensees’ products.

 

We generally record engineering cost as research and development expense in the period incurred, except when the engineering cost is being deferred under a licensing agreement for which technological feasibility has been established.

 

Selling, General and Administrative Expenses.  Selling, general and administrative expenses consist primarily of employee-related expenses and professional fees. Facility and occupancy costs are allocated to each functional department in proportion to its headcount.

 

Critical Accounting Policies

 

Use of estimates.  Our discussion and analysis of our financial condition and results of operation are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make certain estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an ongoing basis we make these estimates based on our historical experience and on assumptions that we consider reasonable under the circumstances. Actual results may differ from these estimates, and reported results could differ under different assumptions or conditions.

 

We believe that the following accounting policies are affected by estimates and judgments in the following manner:

 

Revenue.  If a licensing contract involves performance specifications that we have significant experience in meeting and the cost of contract completion can be reasonably estimated, we recognize the revenue over the period in which the contract services are performed using the percentage of completion method. We follow this method because we can obtain reasonably dependable estimates of the costs to perform the contracted services. Labor costs for the development of the licensee’s design are estimated at the beginning of the contract. As these costs are incurred, they are used as a measure of progress towards completion. We have the ability to reasonably estimate labor cost on a contract-to-contract basis from our previous experience in developing designs for other licensees. During the contract performance period we review estimates of cost to complete the contract as it progresses to completion and will revise our estimates of revenue and gross profit under the contract if we revise the estimations of the cost to complete. Our policy is to reflect any revision in the contract gross profit estimate in reported income for the period in which the facts giving rise to the revision become known. There were no significant changes in estimates of costs to complete contracts during the three-month period ended September 30, 2003.

 

Inventory.  We state inventories at the lower of cost or market, determined using the first-in, first-out method. Our policy is to write down our inventory for estimated obsolescence or unmarketable inventory to the extent the cost exceeds the estimated market value. We estimate fair market value based on our historical sales for the last six months and current market conditions. If actual market conditions are less favorable than those assumed in our estimates, additional inventory write-downs may be required. Our policy is to reflect any write-down of inventory in reported income for the period in which the facts giving rise to the inventory write-down become known.

 

18



 

Impairment of Goodwill.  According to our accounting policy, we performed an annual review of goodwill recorded from the acquisition of ATMOS in August 2002. During the fourth quarter of 2002, we found no impairment based on the undiscounted cash flows test. We will perform the annual impairment test in the third quarter of each year, or more frequently if indicators of potential impairment exist. Our impairment review process is based on the guidance provided in SFAS No. 142, which utilizes a discounted future cash flow. This approach uses our estimates of revenue for the enterprise, driven by assumed market growth rates and assumed market segment share, and estimated costs as well as appropriate discount rates. Changes in our estimate could result in substantial charges for impairment of goodwill.  We performed the annual impairment test during the third quarter of 2003, and the test did not indicate impairment of goodwill as of September 30, 2003.

 

Tax valuation allowance.  When we prepare our consolidated financial statements, we estimate our income tax liability for each of the various jurisdictions where we conduct business. This requires us to estimate our actual current tax exposure and to assess temporary differences that result from differing treatment of certain items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which we show on our consolidated balance sheet under the category of other current assets. The net deferred tax assets are reduced by a valuation allowance if, based upon weighted available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. When we establish a valuation allowance or increase this allowance in an accounting period, we must record a tax expense in our statement of operations. Management must make significant judgments to determine our provision for income taxes, our deferred tax assets and liabilities and any valuation allowance to be recorded against our net deferred tax asset. As of December 31, 2002, we had net operating loss carryforwards of approximately $2.5 million for federal tax purposes that we expect to be available to reduce our current year taxable income and effective tax rate.

 

Results of Operations

 

Three Months Ended September 30, 2003 and 2002

 

Revenue.  Total revenue decreased to $3.5 million for the three months ended September 30, 2003 from $7.0 million for the three months ended September 30, 2002. Licensing revenue decreased to $1.8 million in the third quarter of 2003 from $2.8 million in the same period of 2002 as revenue recognized from new projects did not offset a decline in revenue from existing projects. Licensing revenue represented 51% of total revenue in the third quarter of 2003, compared to 39% in the same period in 2002. Royalty revenue decreased to $1.2 million in the third quarter of 2003 from $3.5million in the same period of 2002, and represented 35% of total revenue in the third quarter of 2003, compared to 50% for the same period in 2002. In the third quarter of 2003, we earned no royalties from the production of Gamecube chips incorporating our 1T-SRAM technology, a significant decrease from 34% of our total revenue from the same period in 2002, as Nintendo delayed its purchases of chips incorporating our licensed technology for its Gamecube consoles.

 

In the three months ended September 30, 2003, product revenue also decreased to $511,000 in the third quarter of 2003 from $784,000 in the same period of 2002. Product revenue represented 15% of total revenue in the third quarter of 2003, compared to 11% in the same period in 2002 because product revenue declined proportionately less than licensing and royalty revenues. We attribute the product revenue decrease primarily to the economic downturn in the communications equipment industry, which is the primary market for our memory chips.

 

A small number of customers continue to account for a significant percentage of our total revenue. For the quarter ended September 30, 2003, our three largest customers, Sony, Marvel and Motorola represented 28%, 11% and 11% of total revenue, respectively. For the three months ended September 30, 2002, our two largest customers, NEC and UMC represented 40% and 15% of total revenue, respectively. For information regarding revenues recorded by us in three months and nine months ended September 30, 2003 and 2002 from customers residing in the United States or residing in a foreign country, please refer to note 5, “Segment Information,” of Notes to Consolidated Financial Statements. All of our sales are denominated in U.S. dollars. For a discussion of certain risks related to our revenue concentration, please see “Risk Factors—We expect our revenue to be concentrated”.

 

Gross Profit.  Gross profit decreased to $2.7 million in the three months ended September 30, 2003 from $6.1 million in the same period of 2002 primarily due to the decrease in royalty and licensing revenue. Gross profit as a percentage of total revenue decreased to 76% in the third quarter of 2003 from 87% in the corresponding period of 2002 primarily due to the decline in royalty revenue, which has no associated costs. Licensing gross profit decreased to 67% in the three months ended September 30, 2003 compared to 84% in the same period of 2002 mainly due to recognition of revenue under some lower margin license projects during the third quarter of 2003. We expect future gross profit of licensing revenue to return to historic levels. In addition, licensing gross profit was greater comparatively in the third quarter of 2002 because it included revenues recognized under the completed contract method of accounting and from canceled projects for which the associated costs had been expensed in preceding periods.  There were no licensing revenues in the third quarter of 2003 for which the associated costs had been expensed in a prior period.

 

Product gross margin as a percentage of product revenue increased to 49% in the third quarter of 2003 compared to 41% in the same quarter of 2002 primarily due to a reduction in manufacturing fixed costs.

 

19



 

Research and Development.  In the third quarter of 2003, research and development expense increased to $2.1 million from $1.7 million in the same period of 2002 with additions to the engineering staff to support our licensing activities and our acquisition of ATMOS in August 2002. Research and development expenses as a percentage of total revenue were 60% and 24% for the quarters ended September 30, 2003 and 2002, respectively.  We anticipate the same level of research and development expenses for the foreseeable future.

 

Selling, General and Administrative.  Selling, general and administrative expenses increased to $1.4 million in the third quarter of 2003 from $1.3 million in the same period of 2002 due primarily to increased sales and marketing activities, including the establishment of a sales office in Japan in January 2003 and higher professional fees. Selling, general and administrative expenses as a percentage of total revenue were 40% and 18% for the quarters ended September 30, 2003 and 2002, respectively.

 

Interest and Other Income.  Interest and other income decreased to $311,000 in the third quarter of 2003 from $392,000 in the same period of 2002 because of lower interest rates on our cash equivalents and investments. Interest and other income as a percent of total revenue were 9% and 6% for the quarters ended September 30, 2003 and 2002, respectively.

 

Provision for Income Taxes.  The Company’s effective tax rate is based on the estimated annual effective tax rate in accordance with Statement of Financial Accounting Standards No. 109 “Accounting for Income Taxes”. A benefit for income taxes of  $468,000 was recorded in the third quarter of 2003 due to a reduction in the annual effective income tax rate to 10% from 20% for 2003. The effective tax rate was reduced primarily due to the impact of reductions in projected profits before tax on anticipated benefits from net operating losses and research and development credits.  The provision of income taxes was  $689,000 and effective tax rate was 20% in the same period 2002. The effective rates were lower than the U.S. federal and state combined statutory rate primarily due to the utilization of net operating losses and research and development credits that had been reserved previously.

 

Nine Months Ended September 30, 2003 and 2002

 

Revenue.  Total revenue decreased to $15.9 million for the nine months ended September 30, 2003 from $20.0 million in the same period of 2002.  Licensing revenue increased to $8.5 million in the first nine months of 2003 from $7.3 million in the same period of 2002 due to an increase in new projects, especially in the first quarter of 2003.  Licensing revenue was 53% of total revenue for the first nine months of 2003, compared to 36% in the same period in 2002. In the nine months ended September 30, 2003, royalty revenue decreased to $5.8 million from $10.4 million in the same period of 2002, and represented 37% of total revenue, compared to 52% in the same period in 2002. In the first nine months of 2003, royalties earned from the production of Gamecube chips incorporating our 1T-SRAM technology represented 13% of total revenue in the first nine months of 2003, a significant decrease from 40% of our total revenue from the same period in 2002, as Nintendo reduced its purchases of chips incorporating our licensed technology for its Gamecube consoles. During the second quarter of 2003, we collected $1.0 million in cash from Conexant for the termination of its October 2000 license agreement with us.  This payment consisted of current and past due royalty payments totaling $713,000, and a termination fee of $287,000, which we included in other income.

 

Product revenue also decreased to $1.6 million in first nine months of 2003 from $2.3 million in the same period of 2002, and represented 10% of total revenue, compared to 12% in the same period in 2002. We attribute the product revenue decrease primarily to the economic downturn in the communications equipment industry, which is the primary market for our memory chips.

 

Gross Profit.  Gross profit decreased to $13.4 million in the first nine months ended September 30, 2003 from $17.5 million in the first nine months period of 2002 as increased licensing revenue failed to offset a decline in royalty and product revenue. Gross profit as a percentage of total revenue decreased to 84% in the first nine months of 2003 from 88% in the corresponding period of 2002 mainly due to the decline in royalty revenue, which has no associated costs. Licensing gross profit declined to 82% in the first nine months of 2003 from 85% in the same quarter of 2002 primarily due to recognition of revenue under some lower margin license projects during the third quarter of 2003.

 

Product gross margin as a percentage of product revenue decreased to 39% in the first nine months of 2003 compared to 44% in the corresponding period of 2002. This decline occurred because our fixed manufacturing overhead costs were spread over a reduced number of units of product shipped in the first nine months of 2003 compared to the same period of 2002. 

 

Research and Development.  Research and development expenses increased to $6.5 million in the nine months ended September 30, 2003 from $4.5 million in the same period of 2002 due to additions to the engineering staff to support to our licensing activities and our acquisition of ATMOS on August 30, 2002. Research and development expenses as a percent of total revenue were 41% and 23% for the nine months ended September 30, 2003 and 2002, respectively. We anticipate the same level of research and development expenses for the foreseeable future.

 

Selling, General and Administrative.  Selling, general and administrative expenses increased to $4.7 million in the first nine months of 2003 from $3.4 million in same period of 2002.  Selling, general and administrative expenses as a percent of total revenue

 

20



 

were 29% and 17% for the nine months ended September 30, 2003 and 2002, respectively.  The increase in percentage was attributable to both the increase in total expense and the decline in total revenues in the nine-month period.

 

Interest and Other Income.  Interest and other income increased to $1.5 million in the first nine months of 2003 from $1.2 million in the same period of 2002 primarily due to the $287,000 termination fee from Conexant recorded as other income.  Interest and other income as a percent of total revenue were 9% and 6% for the nine months ended September 30, 2003 and 2002, respectively.

 

Provision for Income Taxes. Provisions for income taxes of  $325,000 and $2.1 million were recorded in the first nine months of 2003 and 2002, respectively.  The effective income tax rate was 10% for the nine months ended September 30, 2003 and 20% for the same period in 2002. The effective tax rate was reduced primarily due to the impact of reductions in projected profits before tax on anticipated benefits from net operating losses and research and development credits. The effective rates were lower than the U.S. federal and state combined statutory rate primarily due to the utilization of net operating losses and research and development credits that had been reserved previously.

 

Liquidity and Capital Resources

 

As of September 30, 2003, we had cash and cash equivalents of $28.9 million, short-term investments of $7.2 million and long-term investments of $48.3 million. As of the same date, we had total working capital of $40.5 million. Our primary capital requirements are to fund working capital needs. We believe that our current focus on licensing and royalty revenues and reduced levels of memory chip sales has lessened the volatility of our business and generally has enabled us to steadily improve our cash position.

 

Net cash provided by operating activities increased to $3.2 million for the nine months ended September 30, 2003 compared to $3.1 million for the same period of 2002 primarily due to changes in accounts receivable, prepaid expenses and other assets, and accrued expenses and other liabilities offset by a significantly lower net income for the first nine months of 2003. In the nine months ended September 20, 2003, an increase in accounts receivable was mainly due to a decline in license fees receivable compared to the corresponding period of 2002.  A decline in prepaid expenses and other assets in the first nine months of 2003 compared to the same period in 2002 was primarily attributable to lower deferred tax assets and deferred costs.  In addition, higher accrued expenses and other liabilities in the nine months ended September 30, 2003 compared to the same period in 2002 were primarily due to an increase in income tax payable.

 

Net cash used in investing activities was approximately $2.5 million and $35.6 million for the first nine months ended September 30, 2003 and 2002, respectively. Net cash used in investing activities for the first nine months of 2003 consisted primarily of purchases of short-term and long-term marketable securities of $2.0 million, net of proceeds from the disposition of investment securities, compared to $22.5 million in the same period in 2002. Net cash used in investing activities for the first nine months of 2002 also included $12.0 million paid for the acquisition of ATMOS.

 

Net cash provided by financing activities was $1.8 million and $972,000 for the first nine months ended 2003 and 2002, respectively. Most of the cash provided by financing activities for the first nine months of 2003 and 2002 consisted of proceeds of the exercise of employee options to purchase common stock.

 

Our future liquidity and capital requirements are expected to vary from quarter to quarter, depending on numerous factors, including—

 

                                          level and timing of licensing, royalty and memory chip sales revenues;

 

                                          cost, timing and success of technology development efforts;

 

                                          market acceptance of our existing and future technologies and products;

 

                                          competing technological and market developments;

 

                                          cost of maintaining and enforcing patent claims and intellectual property rights;

 

                                          variations in manufacturing yields, materials costs and other manufacturing risks

 

                                          costs of acquiring other businesses and integrating the acquired operations; and

 

•           profitability of our business.

 

We expect that existing short-term and long-term investments along with our existing capital and cash generated from operations, if any, will be sufficient to meet our capital requirements for the foreseeable future. We expect that a licensing business such as ours generally will require less cash to support operations after multiple licensees begin to ship products and pay royalties.

 

21



 

However, we cannot be certain that we will not require additional financing at some point in time. Should our cash resources prove inadequate, we might need to raise additional funding through public or private financing. There can be no assurance that such additional funding will be available to us on favorable terms, if at all. The failure to raise capital when needed could have a material, adverse effect on our business and financial condition.

 

Lease Commitments and Off Balance Sheet Financing

 

The following table identifies our contractual obligations as of September 30, 2003 that will impact our liquidity and cash flow in future periods:

 

 

 

Payment Due by Period

 

 

 

Total

 

Less than 1
year

 

1-3 years

 

4-5 years

 

Over 5 years

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Lease Obligations

 

$

3,333

 

$

1,301

 

$

1,418

 

$

614

 

$

 

Capital Lease Obligations

 

33

 

16

 

17

 

 

 

 

We did not have any unconditional purchase obligations as of September 30, 2003.

 

RISK FACTORS

 

If any of the following risks actually occur, our business, results of operations and financial condition could suffer significantly.

 

Our success depends upon the semiconductor market’s acceptance of our 1T-SRAM technologies.

The future prospects of our business depend on the acceptance by our target markets of our 1T-SRAM technologies for embedded memory applications and any future technology we might develop. Our technology is intended to allow our licensees to develop embedded memory integrated circuits to replace other embedded memory technology with different cost and performance parameters. Our 1T-SRAM technologies utilize fundamentally different internal circuitry that is not widely known in the semiconductor industry. Therefore, one of our principal challenges, which we might fail to meet, is to convince a substantial percentage of SOC designers to adopt our technology instead of other memory solutions which have proven effective in their products.

 

An important part of our strategy to gain market acceptance is to penetrate new markets by targeting market leaders as licensees of our technology. This strategy is designed to encourage other participants in those markets to follow these leaders in adopting our technology. Should a high-profile industry participant adopt our technology for one or more of its products but fail to achieve success with those products, other industry participants’ perception of our technology could be harmed. Any such event could reduce the number of future licenses of our technology. Likewise, were a market leader to adopt and achieve success with a competing technology, our reputation and licensing program could be harmed.

 

Our embedded memory technology might not integrate as well as anticipated with other semiconductor functions in all intended applications, which would slow or prevent adoption of our technology and reduce our revenue. Detailed aspects of our technology could cause unforeseen problems in the efficient integration of our technology with other functions of particular integrated circuits. Any significant compatibility problems with our technology could reduce the attractiveness of our solution, impede its acceptance in the industry and result in a decrease in demand for our technology.

 

We expect our revenue to be highly concentrated among a small number of licensees and customers, and our results of operations could be harmed if we lose and fail to replace this revenue.

Our royalty revenue has been highly concentrated among a few licensees, and we expect this trend to continue for the foreseeable future. In particular, a substantial portion of our licensing and royalty revenue in 2001 and in 2002 has come from the licenses for integrated circuits used by Nintendo in its GAMECUBE®. Gamecube-related revenue represented 0% and 34% of total revenue in the third quarter ended September 30, 2003 and 2002, respectively. Gamecube-related revenue represented 13% and 40% of total revenue in the first nine months of 2003 and 2002, respectively. Gamecube-related revenue represented 44% and 23% of total revenue in 2002 and 2001, respectively. Moreover, Nintendo faces intense competitive pressure in the video game market, which is characterized by extreme volatility, frequent new product introductions and rapidly shifting consumer preferences. Nintendo has publicly announced that its sales of Gamecube units were significantly less than its expectations during its most recent fiscal year ended March 31, 2003. We cannot assure you that Nintendo’s sales of product incorporating our technology will increase or remain at prior period levels. 

 

Furthermore, our overall revenue has been highly concentrated with a few customers accounting for a significant percentage of our total revenue. For the third quarter ended September 30, 2003, our three largest customers, SONY, Marvel and Motorola represented 28%, 11%, and 11% of total revenue, respectively. For the three months ended September 30, 2002, our two largest customers, NEC and UMC represented 40% and 15% of total revenue, respectively. We expect that a relatively small number of licensees will continue to account for a substantial portion of our revenue for the foreseeable future.

 

22



 

As a result of this revenue concentration, our results of operations could be impaired by the decision of a single key licensee or customer to cease using our technology or products or by a decline in the number of products that incorporate our technology that are sold by a single licensee or customer or by a small group of licensees or customers.

 

Our revenue concentration may also pose credit risks, which could negatively affect our cash flow and financial condition.

We might also face credit risks associated with the concentration of our product revenue among a small number of licensees and customers. As of September 30, 2003, five customers represented 50% of total trade receivables. As of September 30, 2002, two customers accounted for 66% of total trade receivables. Our failure to collect receivables from any customer that represents a large percentage of receivables on a timely basis, or at all, could adversely affect our cash flow or results of operations and might cause our stock price to fall.

 

Anything that negatively affects the businesses of our licensees could negatively impact our revenue.

The timing and level of our royalties depend on our licensees’ ability to market, produce and ship products incorporating our technology. Because we expect licensing and royalty revenue to be the largest source of our future revenue, anything that negatively affects a significant licensee or group of licensees could negatively affect our results of operations and financial condition. Many issues beyond our control influence the success of our licensees, including, for example, the highly competitive environment in which they operate, the strength of the markets for their products, their engineering capabilities and their financial and other resources.

 

Likewise, we have no control over the product development, pricing and marketing strategies of our licensees, which directly affect sales of their products and the corresponding royalties payable to us. A decline in sales of our licensees’ royalty-generating products for any reason would reduce our royalty revenue. In addition, seasonal and other fluctuations in demand for our licensees’ products could cause our operating results to fluctuate, which could cause our stock price to fall.  For example, one of our most significant licensees, NEC, has sustained a prolonged decline in sales of chips incorporating 1T-SRAM technology to Nintendo, and we are unable to predict when or if such sales will recover.

 

Our embedded memory technology is new and the occurrence of manufacturing difficulties, or low production yields could hinder market acceptance of our technology and reduce future revenue.

Complex technology like ours often may contain errors or defects when first incorporated into customer products. For example, semiconductor manufacturing yield could be adversely affected by difficulties in adapting our 1T-SRAM technologies to our licensees’ product design or to the manufacturing process technology of a particular foundry or semiconductor manufacturer. Any decrease in manufacturing yields of integrated circuits utilizing our technology could impede the acceptance of our technology in the industry. The discovery of defects or problems regarding the reliability, quality or compatibility of our technology could require significant expenditures and resources to fix, significantly delay or hinder market acceptance of our technology, reduce anticipated revenues and damage our reputation.

 

Our lengthy licensing cycle and our licensees’ lengthy product development cycles make the operating results of our licensing business difficult to predict.

We anticipate difficulty in accurately predicting the timing and amounts of revenue generated from licensing our 1T-SRAM technologies. The establishment of a business relationship with a potential licensee is a lengthy process, generally taking from three to six months, and sometimes longer. Following the establishment of the relationship, the negotiation of licensing terms can be time-consuming, and a potential licensee may require an extended evaluation and testing period.

 

Once a license agreement has been executed, the timing and amount of licensing and royalty revenue from our licensing business will remain difficult to predict. The completion of the licensees’ development projects and the commencement of production will be subject to the licensees’ efforts, development risks and other factors outside our control. Our royalty revenue may depend on such factors as the licensees’ production and shipment volumes, the timing of product shipments and when the licensees report to us the manufacture or sale of products that include our 1T-SRAM technologies. All of these factors will prevent us from making predictions of revenue with any certainty and could cause us to experience substantial period-to-period fluctuations in operating results.

 

In addition, none of our licensees are under any obligation to incorporate our technology in any present or future product or to pursue the manufacture or sale of any product incorporating our technology. A licensee’s decision to complete a project or manufacture a product is subject to changing economic, marketing or strategic factors. The long development cycle of our licensees’ products increases the risk that these factors will cause the licensee to change its plans. In the past, some of our licensees have discontinued development of products incorporating our technology. These customers’ decisions were based on factors unrelated to our technology, but, as a result, it is unlikely that we will receive royalties in connection with those products. We expect that, from time to time, our licensees will discontinue a product line or cancel a product introduction, which could adversely affect our future operating results and business.

 

23



 

Our failure to continue to enhance our technology or develop new technology on a timely basis could diminish our ability to attract and retain licensees and product customers.

The existing and potential markets for memory products and technology are characterized by ever increasing performance requirements, evolving industry standards, rapid technological change and product obsolescence. These characteristics lead to frequent new product and technology introductions and enhancements, shorter product life cycles and changes in consumer demands. In order to attain and maintain a significant position in the market, we will need to continue to enhance our technology in anticipation of these market trends.

 

In addition, the semiconductor industry might adopt or develop a completely different approach to utilizing memory for many applications, which could render our existing technology unmarketable or obsolete. We might not be able to successfully develop new technology, or adapt our existing technology, to comply with these innovative standards.

 

Our future performance depends on a number of factors, including our ability to—

 

                                          identify target markets and relevant emerging technological trends, including new standards and protocols;

 

                                          develop and maintain competitive technology by improving performance and adding innovative features that differentiate our technology from alternative technologies;

 

                                          enable the incorporation of enhanced technology in our licensees’ and customers’ products on a timely basis and at competitive prices; and

 

                                          respond effectively to new technological developments or new product introductions by others.

 

Since its introduction in 1998, we have introduced enhancements to our 1T-SRAM technology designed to meet market requirements. However, we cannot assure you that the design and introduction schedules of any additions and enhancements to our existing and future technology will be met, that this technology will achieve market acceptance or that we will be able to license this technology on terms that are favorable to us. Our failure to develop future technology that achieves market acceptance could harm our competitive position and impede our future growth.

 

We have an initial history of operating losses, have achieved quarterly profitability consistently only since the third quarter of 2000 and cannot provide assurance of our future profitability.

We recorded operating losses in each year from our inception through 1998. From our inception through 1994, we were engaged primarily in research and product development. From 1995 through the third quarter of 1998, we focused on the sale of memory chips. Beginning in the fourth quarter of 1998, we altered our business plan to concentrate on developing and licensing our 1T-SRAM technology. Prior to the quarter ended September 30, 2000, we had recorded operating losses in each quarter since our entry into the licensing business. We have been profitable each quarter since the third quarter of 2000 up to the third quarter ended September 30, 2003, which resulted in a net loss.  We are offering a relatively new technology and cannot assure you that we will be profitable on a quarterly or annual basis in the future.

 

We rely on semiconductor foundries to assist us in attracting potential licensees, and a loss or failure of these relationships could inhibit our growth and reduce our revenue.

Part of our marketing strategy relies upon our relationships and agreements with semiconductor foundries. These foundries have existing relationships, and continually seek new relationships, with companies in the markets we target, and have agreed to utilize these relationships to introduce our technology to potential licensees. If we fail to maintain our current relationships with these foundries, we might fail to achieve anticipated growth.

 

Royalty amounts owed to us might be difficult to verify, and we might find it difficult, expensive and time-consuming to enforce our license agreements.

The standard terms of our license agreements require our licensees to document the manufacture and sale of products that incorporate our technology and report this data to us after the end of each quarter. We must rely to a large extent upon the accuracy of these reports, as we do not have the capacity to independently verify this information. Though our standard license terms give us the right to audit the books and records of any licensee to attempt to verify the information provided to us in these reports, an audit of a licensee’s records can be expensive and time consuming, and potentially detrimental to the business relationship. A failure to fully enforce the royalty provisions of our license agreements could cause our revenue to decrease and impede our ability to maintain profitability.

 

We might not be able to protect and enforce our intellectual property rights, which could impair our ability to compete and reduce the value of our technology.

Our technology is complex and is intended for use in complicated integrated circuits. A very large number of new and existing products utilize embedded memory, and a large number of companies manufacture and market these products. Because of

 

24



 

these factors, policing the unauthorized use of our intellectual property is difficult and expensive. We cannot be certain that we will be able to detect unauthorized use of our technology or prevent other parties from designing and marketing unauthorized products based on our technology. Although we are not aware of any past or present infringement of our patents, copyrights or trademarks, or any violation of our trade secrets, confidentiality procedures or licensing agreements, we cannot assure you that the steps taken by us to protect our proprietary information will be adequate to prevent misappropriation of our technology. Our inability to protect adequately our intellectual property would reduce significantly the barriers of entry for directly competing technologies and could reduce the value of our technology. Furthermore, we might initiate claims or litigation against third parties for infringement of our proprietary rights or to establish the validity of our proprietary rights. Litigation by us could result in significant expense and divert the efforts of our technical and management personnel, whether or not such litigation results in a determination favorable to us.

 

Our existing patents might not provide us with sufficient protection of our intellectual property, and our patent applications might not result in the issuance of patents, either of which could reduce the value of our core technology and harm our business.

We rely on a combination of patents, trademarks, copyrights, trade secret laws and confidentiality procedures to protect our intellectual property rights. As of September 30, 2003, we held 60 patents in the United States, which expire at various times from 2011 to 2023, and 30 corresponding foreign patents. In addition, as of September 30, 2003, we had 18 patent applications pending in the United States and 25 pending foreign applications, and had received notice of allowance of 5 patent applications pending in the United States. We cannot be sure that any patents will issue from any of our pending applications or that any claims allowed from pending applications will be of sufficient scope or strength, or issued in all countries where our products can be sold, to provide meaningful protection or any commercial advantage to us. Also, competitors might be able to design around our patents. Failure of our patents or patent applications to provide meaningful protection might allow others to utilize our technology without any compensation to us and impair our ability to increase our licensing revenue.

 

Any claim that our products or technology infringe third-party intellectual property rights could increase our costs of operation and distract management and could result in expensive settlement costs or the discontinuance of our technology licensing or product offerings.

The semiconductor industry is characterized by vigorous protection and pursuit of intellectual property rights or positions, which has resulted in often protracted and expensive litigation. We are not aware of any currently pending intellectual property litigation or threatened claim against us. However, our licensees or we might, from time to time, receive notice of claims that we have infringed patents or other intellectual property rights owned by others. Litigation against us could result in significant expense and divert the efforts of our technical and management personnel, whether or not the litigation results in a determination adverse to us. In the event of an adverse result in any such litigation, we could be required to pay substantial damages, cease the licensing of certain technology or the sale of infringing products, and expend significant resources to develop non-infringing technology or obtain licenses for the infringing technology. We cannot assure you that we would be successful in such development or that such licenses would be available on reasonable terms, or at all.

 

The discovery of defects in our technology could expose us to liability for damages.

The discovery of a defect in our 1T-SRAM technology could lead our licensees to seek damages from us. Our standard license terms include provisions waiving implied warranties regarding our technology and limiting our liability to our licensees. We also maintain insurance coverage that is intended to protect us against potential liability for defects in our technology. We cannot be certain, however, that the waivers or limitations of liability contained in our license contracts will be enforceable, that insurance coverage will continue to be available on reasonable terms or in amounts sufficient to cover one or more large claims or that our insurer will not disclaim coverage as to any future claim. The successful assertion of one or more large claims that exceed available insurance coverage or changes in our insurance policies, including premium increases or the imposition of large deductible or co-insurance requirements, could cause our expenses to rise significantly and consequently harm our profitability.

 

Our failure to compete effectively in the market for embedded memory technology and products could reduce our revenue.

Competition in the market for embedded memory technologies and products is intense. Our licensees and prospective licensees can meet their need for embedded memory by using traditional memory solutions with different cost and performance parameters, which they may internally develop or acquire from third party vendors. If alternative technologies are developed that provide comparable system performance at lower cost than our 1T-SRAM technologies or do not require the payment of comparable royalties, or if the industry generally demonstrates a preference for applications for which our 1T-SRAM technologies do not offer significant advantages, our ability to realize revenue from our 1T-SRAM technologies could be impaired.

 

We might be challenged by competitive developers of alternative technologies who are more established, benefit from greater market recognition and have substantially greater financial, development, manufacturing and marketing resources than we have. These advantages might permit these developers to respond more quickly to new or emerging technologies and changes in licensee requirements. We cannot assure you that future competition will not have a material adverse effect on the adoption of our technology and our market penetration.

 

25



 

We might be unable to deliver our customized memory technology in the time frame demanded by our licensees, which could damage our reputation, harm our ability to attract future licensees and impact operating results.

The majority of our licenses require us to customize our 1T-SRAM technologies within a certain delivery timetable. Not all of the factors relating to this customization are within our control. We cannot assure you that we will be able to meet the time requirements under these licenses. Any failure to meet significant license milestones could damage our reputation in the industry, harm our ability to attract new licensees and could preclude our receipt of licensing fees and negatively impact operating results.

 

Generating and recognizing licensing revenue under these contracts depends on our ability to successfully meet milestones for delivery of 1T-SRAM designs and services. Occasionally, we may fail to meet a delivery date or performance criterion, thereby resulting in a delay in revenue recognition or loss of anticipated revenue.

 

We intend to grow rapidly, and our failure to manage this growth could reduce our potential revenue and threaten our future profitability.

The efficient management of our planned expansion of the development, licensing and marketing of our technology, including through the acquisition of other companies will require us to continue to—

 

                                          implement and manage new marketing channels to penetrate different and broader markets for our 1T-SRAM technologies;

 

                                          manage an increasing number of complex relationships with licensees and co-marketers and their customers and other third parties;

 

                                          improve our operating systems, procedures and financial controls on a timely basis;

 

                                          hire additional key management and technical personnel; and

 

                                          expand, train and manage our workforce and, in particular, our development, sales, marketing and support organizations.

 

We cannot assure you that we will adequately manage our growth or meet the foregoing objectives. A failure to do so could jeopardize our future revenues and cause our stock price to fall.

 

Any acquisitions we make, such as our acquisition of ATMOS Corporation, could disrupt our business and harm our financial condition.

As part of our growth strategy, we might consider opportunities to acquire other businesses or technologies that would complement our current offerings, expand the breadth of our markets or enhance our technical capabilities. ATMOS Corporation is our only acquisition to date. Acquisitions present a number of potential challenges that could, if not overcome, disrupt our business operations, increase our operating costs and reduce the value to us of the acquired company, including—

 

                                          integration of the acquired employees, operations, technologies and products with our existing business and products;

 

                                          focusing management’s time and attention on our core business;

 

                                          retention of business relationships with suppliers and customers of the acquired company;

 

                                          entering markets in which we lack prior experience;

 

                                          retention of key employees of the acquired company; and

 

                                          amortization of intangible assets, write-offs, stock-based compensation and other charges relating to the acquired business and our acquisition costs.

 

If we fail to retain key personnel, our business and growth could be negatively affected.

Our business has been dependent to a significant degree upon the services of a small number of executive officers and technical employees, including Dr. Fu-Chieh Hsu, our Chairman of the Board, President and Chief Executive Officer, and Dr. Wingyu Leung, our Executive Vice President and Chief Technical Officer. The loss of their services could negatively impact our technology development efforts and our ability to perform our existing agreements and obtain new customers. We generally have not entered into

 

26



 

employment or non-competition agreements with any of our employees and do not maintain key-man life insurance on the lives of any of our key personnel.

 

In 2002 and the first nine months of 2003, we experienced a decline in revenue from sales of our stand alone memory chips, and in light of weak demand from our customers, product revenue and gross margin are likely to decline further from current levels.

Product revenues since 1998, when we changed our business strategy, have represented 11%, 58%, and 90% of our total revenues in 2002, 2001 and 2000, respectively. Our product revenues fell to $1.6 million in the first nine months of 2003 from $2.3 million in the same period of 2002 representing 10% and 12% of total revenue, respectively. This decline resulted from a general weakness in demand for our customers’ products, which we expect will persist for the foreseeable future. As our product revenues continue to decline, any future quarterly growth in our revenue and net income will have to arise from our licensing business, or our operating results will be affected adversely.

 

The volatility of and uncertainties inherent in the semiconductor industry may make it difficult to plan our memory chip business and could cause our results of operations to fluctuate substantially.

In the past, we have generally experienced significant fluctuations in our operating results due to significant economic downturns in the semiconductor industry. Specifically, in 1998 and again from late 2000 to date, product demand fell, prices eroded and inventory levels fluctuated. Our ability to sell memory chips has also been hampered by alternating periods of manufacturing over-capacity and capacity constraints. Any recurrence of these conditions could cause us to experience substantial period-to-period fluctuations in revenues and costs associated with our memory chip business.

 

Our failure to successfully address the potential difficulties associated with our international operations could increase our costs of operation and negatively impact our revenue.

We are subject to many difficulties posed by doing business internationally, including—

 

                                          foreign currency exchange fluctuations;

 

                                          unanticipated changes in local regulation;

 

                                          potentially adverse tax consequences, such as withholding taxes;

 

                                          difficulties regarding timing and availability of export and import licenses;

 

                                          political and economic instability; and

 

                                          reduced or limited protection of our intellectual property.

 

Because we anticipate that licenses to companies that operate primarily outside the United States will account for a substantial portion of our licensing revenue in future periods, the occurrence of any of these circumstances could significantly increase our costs of operation, delay the timing of our revenue and harm our profitability.

 

Provisions of our certificate of incorporation and bylaws or Delaware law might delay or prevent a change of control transaction and depress the market price of our stock.

Various provisions of our certificate of incorporation and bylaws might have the effect of making it more difficult for a third party to acquire, or discouraging a third party from attempting to acquire, control of our company. These provisions could limit the price that certain investors might be willing to pay in the future for shares of our common stock. Certain of these provisions eliminate cumulative voting in the election of directors, limit the right of stockholders to call special meetings and establish specific procedures for director nominations by stockholders and the submission of other proposals for consideration at stockholder meetings.

 

We are also subject to provisions of Delaware law which could delay or make more difficult a merger, tender offer or proxy contest involving our company. In particular, Section 203 of the Delaware General Corporation Law prohibits a Delaware corporation from engaging in any business combination with any interested stockholder for a period of three years unless specific conditions are met. Any of these provisions could have the effect of delaying, deferring or preventing a change in control, including without limitation, discouraging a proxy contest or making more difficult the acquisition of a substantial block of our common stock.

 

Our board of directors may issue up to 20,000,000 shares of preferred stock without stockholder approval on such terms as the board might determine. The rights of the holders of common stock will be subject to, and might be adversely affected by, the rights of the holders of any preferred stock that might be issued in the future.

 

27



 

Our stockholder rights plan could prevent stockholders from receiving a premium over the market price for their shares from a potential acquiror.

We have adopted a stockholder rights plan, which entitles our stockholders to rights to acquire additional shares of our common stock generally when a third party acquires 15% of our common stock or commences or announces its intent to commence a tender offer for at least 15% of our common stock. This plan could delay, deter or prevent an investor from acquiring us in a transaction that could otherwise result in stockholders receiving a premium over the market price for their shares of common stock.

 

A limited number of stockholders will have the ability to influence the outcome of director elections and other matters requiring stockholder approval.

Our executive officers, directors and their affiliates or non-affiliate  related entities, in the aggregate, beneficially own approximately 36% of our common stock. These stockholders acting together have the ability to exert substantial influence over all matters requiring the approval of our stockholders, including the election and removal of directors and any proposed acquisition, consolidation or sale of all or substantially all of our assets. In addition, they could dictate the management of our business and affairs. This concentration of ownership could have the effect of delaying, deferring or preventing a change in control, or impeding an acquisition, consolidation, takeover or other business combination, which might otherwise involve the payment of a premium for your shares of our common stock.

 

Potential volatility of the price of our common stock could negatively affect your investment.

We cannot assure you that there will continue to be an active trading market for our common stock. Recently, the stock market, as well as our common stock, has experienced significant price and volume fluctuations. Market prices of securities of technology companies have been highly volatile and frequently reach levels that bear no relationship to the operating performance of such companies. These market prices generally are not sustainable and are subject to wide variations. If our common stock trades to unsustainably high levels, it is likely that the market price of our common stock will thereafter experience a material decline.

 

In the past, securities class action litigation has often been brought against a company following periods of volatility in the market price of its securities. We could be the target of similar litigation in the future. Securities litigation could cause us to incur substantial costs, divert management’s attention and resources, harm our reputation in the industry and the securities markets and reduce our profitability.

The price of our stock could decrease as a result of shares being sold in the market by directors, officers and other significant stockholders.

Sales of a substantial number of shares of common stock in the public market could adversely affect the market price of the common stock prevailing from time to time. The number of shares of our common stock available for sale in the public market is limited by restrictions under the Securities Act of 1933, as amended, or the Securities Act, but taking into account sales of stock made in accordance with the provisions of Rules 144(k), 144 and 701, substantially all the shares of common stock currently outstanding are eligible for sale in the public market.

 

Dr. Fu-Chieh Hsu, our Chairman of the Board, President and Chief Executive Officer, Mark Eric Jones, our Vice President and General Manager and Andre Hassan, our Vice President and General Manager each entered into a plan for selling a portion of their shares of common stock in the manner described under Rule 10b5-1 of the Securities Exchange Act of 1934. Each plan is non-discretionary and is administered by an independent brokerage firm. The plan for Dr. Hsu provides for the sale of up to 240,000 shares in blocks of 20,000 shares per month pursuant to limit orders at specified prices. The duration of his plan is from August 19, 2003 to August 18, 2004. The plan for Mr. Jones provides for the sale of up to 150,000 shares in blocks of at least 5,000 shares per week pursuant to limit orders at specified prices. The duration of his plan is from February 1, 2003 to January 31, 2004. Mr. Hassan’s plan provides for the sale of up to 50,000 shares pursuant to limit orders to sell at a specified price and expires in 12 months or sooner upon the occurrence of certain events, which are not within his control. His plan became effective on August 28, 2003. Sales of the shares are further subject to the volume restrictions set forth in SEC Rule 144(e). Each plan provides for termination upon the completion of the specified trading program, the instruction of the stockholder, or the occurrence of other specified events, whichever is earliest. All of the shares are sold through broker-dealers in ordinary market transactions.

 

ITEM 3. Qualitative and Quantitative Disclosure about Market Risk

 

Our investment portfolio consists of money market funds, corporate-backed debt obligations and mortgage-backed government obligations generally due within one year. Our primary objective with this investment portfolio is to invest available cash while preserving principal and meeting liquidity needs. In accordance with our investment policy, we place investments with high credit quality issuers and limit the amount of credit exposure to any one issuer. These securities, which approximated $79.7 million as of September 30, 2003, and have an average interest rate of approximately 1.58%, are subject to interest rate risks. However, based on the investment portfolio contents and our ability to hold these investments until maturity, we believe that if a significant change in interest rates were to occur, it would not have a material effect on our financial condition.

 

28



 

ITEM 4. Controls and Procedures

 

(a)                                  Evaluation of disclosure controls and procedures

 

Within the 90-day period prior to the date of this report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-14 of the Securities Exchange Act of 1934 (the “Exchange Act”). Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective in timely alerting them to material information relating to the Company (including its consolidated subsidiaries) required to be included in the Company’s Exchange Act filings.

 

(b)                                 Changes in internal controls

 

There have been no significant changes in the Company’s internal controls or in other factors, which could significantly affect internal controls subsequent to the date the Company carried out its evaluation.

 

 

PART II—OTHER INFORMATION

 

ITEM 2. Changes in Securities and Use of Proceeds

 

The Securities and Exchange Commission declared the Company’s first registration statement, filed on Form S-1 under the Securities Act of 1933 (File No. 333-43122) relating to the Company’s initial public offering of its common stock, effective on June 27, 2001. The Company realized approximately $51,554,000 after offering expenses. To date, the Company has not used any of the net proceeds of the offering. Following the completion of the offering, all series of the Company’s issued and outstanding preferred stock, par value $0.01, converted automatically into 12,731,446 shares of common stock with a par value of $0.01 per share.

 

ITEM 6.   Exhibits and Reports on Form 8-K

 

(a)                                  Exhibits

 

31.1                           Rule 13a-14 certification

31.2                           Rule 13a-14 certification

32                                Section 1350 certification

 

(b)                                 Reports on Form 8-K

 

On July 17, 2003, the Company filed a report on Form 8-K regarding the Company’s results of operations and financial condition for the second quarter of 2003.

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Dated: November 13, 2003

 

 

 

/s/ Mark Voll

 

Vice President, Finance and Administration

 

Chief Financial Officer and Secretary

 

(Duly Authorized and Principal Accounting Officer)

 

29